. -e), AECC (EU-FP7-201663), and NIH RO-1 (CA089715), ) to J.M. Paramio, and MMA Foundation grant AP99782012 to M. Dueñas. We also acknowledge TCGA Research Network for freely providing genomic data

K. G. Guruharsha and M. W. Kankel, Artavanis-Tsakonas S. The Notch signalling system: recent insights into the complexity of a conserved pathway, Nat Rev Genet, vol.13, issue.9, pp.654-666, 2012.

P. Ntziachristos, J. S. Lim, J. Sage, and I. Aifantis, From fly wings to targeted cancer therapies: a centennial for notch signaling, Cancer Cell, vol.25, issue.3, pp.318-334, 2014.

A. P. Weng, Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia, Science, vol.306, issue.5694, pp.269-271, 2004.

X. S. Puente, Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia, Nature, vol.475, issue.7354, pp.101-105, 2011.

B. Westhoff, Alterations of the Notch pathway in lung cancer, Proc Natl Acad Sci U S A, vol.106, issue.52, pp.22293-22298, 2009.

N. Agrawal, Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1, Science, vol.333, issue.6046, pp.1154-1157, 2011.

N. Stransky, The mutational landscape of head and neck squamous cell carcinoma, Science, vol.333, issue.6046, pp.1157-1160, 2011.

N. J. Wang, Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma, Proc Natl Acad Sci U S A, vol.108, issue.43, pp.17761-17766, 2011.

A. Klinakis, A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia, Nature, vol.473, issue.7346, pp.230-233, 2011.

J. N. Eble, G. Sauter, J. I. Epstein, and I. A. Sesterhenn, Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, 2004.

E. Scosyrev, J. Yao, and E. Messing, Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment?, Urology, vol.73, issue.4, pp.822-827, 2009.

, Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma, Nature, vol.507, issue.7492, pp.315-322, 2014.

C. Balbas-martinez, Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy, Nat Genet, vol.45, issue.12, pp.1464-1469, 2013.

G. Guo, Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation, Nat Genet, vol.45, issue.12, pp.1459-1463, 2013.

J. Cordle, A conserved face of the Jagged/ Serrate DSL domain is involved in Notch trans-activation and cis-inhibition, Nat Struct Mol Biol, vol.15, issue.8, pp.849-857, 2008.

M. R. Hass, C. Sato, R. Kopan, and G. Zhao, Presenilin: RIP and beyond, Semin Cell Dev Biol, vol.20, issue.2, pp.201-210, 2009.

R. Kopan and M. X. Ilagan, The canonical Notch signaling pathway: unfolding the activation mechanism, Cell, vol.137, issue.2, pp.216-233, 2009.

C. A. Saura, Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration, Neuron, vol.42, issue.1, pp.23-36, 2004.

K. Tanigaki, Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells, Nat Immunol, vol.3, issue.5, pp.443-450, 2002.

A. M. Puzio-kuter, Inactivation of p53 and Pten promotes invasive bladder cancer, Genes Dev, vol.23, issue.6, pp.675-680, 2009.

X. Mao, Y. Fujiwara, and S. H. Orkin, Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice, Proc Natl Acad Sci U S A, vol.96, issue.9, pp.5037-5042, 1999.

K. Shin, Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma, Nat Cell Biol, vol.16, issue.5, pp.469-478, 2014.

G. T. Bryan, The pathogenesis of experimental bladder cancer, Cancer Res, vol.37, pp.2813-2816, 1977.

I. Garcia-cao, Tumour-suppression activity of the proapoptotic regulator Par4, EMBO Rep, vol.6, issue.6, pp.577-583, 2005.

P. G. Chu, M. H. Lyda, and L. M. Weiss, Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours, Histopathology, vol.39, issue.1, pp.9-16, 2001.

L. Espinosa, The Notch/Hes1 pathway sustains NF-kappaB activation through CYLD repression in T cell leukemia, Cancer Cell, vol.18, issue.3, pp.268-281, 2010.

A. Maraver, Therapeutic effect of gamma-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK, Cancer Cell, vol.22, issue.2, pp.222-234, 2012.

T. Palomero, Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia, Nat Med, vol.13, issue.10, pp.1203-1210, 2007.

A. A. Wendorff, Hes1 is a critical but context-dependent mediator of canonical Notch signaling in lymphocyte development and transformation, Immunity, vol.33, issue.5, pp.671-684, 2010.

M. A. Nieto, Epithelial plasticity: a common theme in embryonic and cancer cells, Science, vol.342, issue.6159, p.1234850, 2013.

P. J. Real, ?-Secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia, Nat Med, vol.15, issue.1, pp.50-58, 2009.

M. Santos, In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer. Cancer Res, vol.74, pp.6565-6577, 2014.

D. R. Rhodes, ONCOMINE: a cancer microarray database and integrated data-mining platform, Neoplasia, vol.6, issue.1, pp.1-6, 2004.

M. Sanchez-carbayo, N. D. Socci, J. Lozano, F. Saint, and C. Cordon-cardo, Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays, J Clin Oncol, vol.24, issue.5, pp.778-789, 2006.

J. S. Lee, Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors, J Clin Oncol, vol.28, issue.16, pp.2660-2667, 2010.

Y. B. Gao, Genetic landscape of esophageal squamous cell carcinoma, Nat Genet, vol.46, issue.10, pp.1097-1102, 2014.

A. G. Abdou, M. M. El-wahed, M. A. Kandil, R. M. Samaka, and N. Elkady, Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma, APMIS, vol.121, issue.10, pp.982-996, 2013.

W. Li, High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder, Int J Clin Exp Pathol, vol.6, issue.11, pp.2430-2440, 2013.

S. Hirao, Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer, Cancer, vol.104, issue.9, pp.1918-1923, 2005.

T. P. Shi, Association of low expression of notch-1 and jagged-1 in human papillary bladder cancer and shorter survival, J Urol, vol.180, issue.1, pp.361-366, 2008.

T. Rafnar, Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer, Hum Mol Genet, vol.23, issue.20, pp.5545-5557, 2014.

B. J. Nickoloff, J. Z. Qin, V. Chaturvedi, M. F. Denning, B. Bonish et al., Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-?B and PPAR?, Cell Death Differ, vol.9, issue.8, pp.842-855, 2002.

A. Rangarajan, Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation, EMBO J, vol.20, issue.13, pp.3427-3436, 2001.

M. P. Alcolea, P. Greulich, A. Wabik, J. Frede, B. D. Simons et al., Differentiation imbalance in single oesophageal progenitor cells causes clonal immortalization and field change, Nat Cell Biol, vol.16, issue.6, pp.615-622, 2014.

I. Espinoza and L. Miele, Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells, Cancer Lett, vol.341, issue.1, pp.41-45, 2013.

P. J. Real and A. A. Ferrando, NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia, Leukemia, vol.23, issue.8, pp.1374-1377, 2009.

A. Maraver and M. Serrano, Notching up a new therapeutic strategy for non-small cell lung carcinoma (NSCLC), Oncotarget, vol.3, issue.9, pp.917-918, 2012.

R. Plentz, Inhibition of ?-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma. Gastroenterology, vol.136, pp.1741-1749, 2009.

J. H. Van-es, Notch/?-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells, Nature, vol.435, issue.7044, pp.959-963, 2005.

A. F. Schott, Preclinical and clinical studies of ? secretase inhibitors with docetaxel on human breast tumors, Clin Cancer Res, vol.19, issue.6, pp.1512-1524, 2013.

S. Hernandez, Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas, J Clin Oncol, vol.24, issue.22, pp.3664-3671, 2006.